GlassScriptPhysician profile
Benjamin J Korf
NPI 1578948022
$848.27
in general payments reported to CMS, 2019-2025
23 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $77.57 · 2023: $180 · 2024: $106 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $134.18 | 2023-2025 | |
| Lilly USA, LLC | $127.44 | 2021-2023 | Mounjaro, Emgality, Reyvow |
| Pfizer INC. | $107.99 | 2024-2025 | |
| Amgen INC. | $50.46 | 2022 | |
| Viatris Specialty LLC | $48.07 | 2025 | Yupelri |
| Sanofi Pasteur INC. | $39.30 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.20 | 2024 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $27.11 | 2022 | |
| Soleno Therapeutics, INC. | $26.79 | 2025 | Vykat Xr |
| Viiv Healthcare Company | $22.96 | 2023 | Apretude |
| Hologic Sales and Service, LLC | $22.14 | 2023 | Aptima, Thinprep 2000 Processor |
| Aimmune Therapeutics, INC. | $21.56 | 2025 | Zenpep |
| Sunovion Pharmaceuticals INC. | $19.74 | 2021 | |
| Janssen Biotech, INC. | $18.25 | 2025 | Tremfya |
| Philips North America LLC | $18.16 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $17.88 | 2021 | |
| Astellas Pharma US INC | $17.79 | 2025 | Veozah |
| Axsome Therapeutics, INC. | $17.63 | 2025 | Symbravo |
| Glaxosmithkline, LLC. | $17.40 | 2025 | Shingrix, Arexvy, Bexsero |
| Astrazeneca Pharmaceuticals LP | $16.70 | 2023 | Breztri |
| Novo Nordisk INC | $15.14 | 2024 | Wegovy |
| Exact Sciences Corporation | $14.59 | 2025 | Cologuard Collection Kit |
| Biodelivery Sciences International, INC. | $11.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Korf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.